A
$ Value
$0
Shares
15,625
Price
$0
Filed
Aug 25
Insider
Name
Odence-Ford Marion
Title
Chief Legal & Admin Officer
CIK
0001845002
Roles
Officer
Transaction Details
Transaction Date
2025-08-21
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
85,901
Footnotes
Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date. | The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.
Filing Info
Odence-Ford Marion's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-23 | OPRX | F | $52K |
| 2025-12-19 | OPRX | M | $0 |
| 2025-12-19 | OPRX | F | $16K |
| 2025-12-19 | OPRX | M | $0 |
| 2025-10-03 | OPRX | M | $0 |
| 2025-10-03 | OPRX | F | $37K |
| 2025-10-03 | OPRX | M | $0 |
| 2025-08-21 | OPRX | A | $0 |
| 2025-08-21 | OPRX | A | $0 |
Other Insiders at OPRX (90d)
No other insider activity at this issuer in the last 90 days.